V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 280007545 | 280004834 | 1.8 | 74.6 | Neo-adjuvant (N) | 2017-04-10 | 2017-04-24 | CISPLATIN + DOCETAXEL + FLUOROURACIL | 2 | null | 280024922 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280007546 | 280008565 | 1.56 | 62.3 | null | null | 2016-04-12 | Carboplatin AUC 2 - 5 | N | N | 280024926 | CARBOPLATIN |
| 280007547 | 280008565 | 1.6 | 74.6 | Neo-adjuvant (N) | 2015-07-29 | 2015-08-07 | Olaratumab | 2 | N | 280024926 | NOT MATCHED |
| 280007548 | 280004841 | 1.6 | null | Curative (C) | 2016-05-04 | 2016-05-11 | Carboplatin AUC 6 - 10 | 02 | N | 280024927 | CARBOPLATIN |
| 280007549 | 280004843 | 1.7 | null | Curative (C) | 2013-09-01 | 2013-09-01 | Carboplatin AUC 6 - 10 | 02 | null | 280024929 | CARBOPLATIN |
| 280007550 | 280004844 | 0 | null | Neo-adjuvant (N) | 2013-07-26 | 2014-07-16 | EW EuroEwing 2012 Arm B VC | Y | N | 280024930 | NOT MATCHED |
| 280007551 | 280004845 | null | null | Curative (C) | 2019-01-01 | 2019-02-22 | CARBOPLATIN | null | null | 280024930 | CARBOPLATIN |
| 280007552 | 280004846 | 1.71 | 121 | Curative (C) | 2015-11-25 | 2016-05-01 | Cetuximab 7 day (>Cycle 2) | 02 | null | 280024936 | CETUXIMAB |
| 280007553 | 280004847 | 0 | null | Curative (C) | 2014-07-17 | 2014-07-24 | null | 02 | N | 280024937 | NOT MATCHED |
| 280007554 | 280004848 | 1.8 | 69.7 | Adjuvant (A) | 2013-07-27 | 2014-03-14 | STS Rhabdo VIT0910 Vinc Irino Temoz | N | N | 280024942 | NOT MATCHED |
| 280007555 | 280004848 | 1.61 | 29.7 | Curative (C) | 2018-09-29 | 2018-09-29 | Carboplatin AUC 6 - 10 | N | N | 280024942 | CARBOPLATIN |
| 280007556 | 280004848 | 1.63 | 19.9 | Neo-adjuvant (N) | 2015-10-22 | 2015-11-12 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | N | 280024942 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280007558 | 280008571 | 1.64 | 91.5 | Curative (C) | 2018-07-22 | 2018-08-02 | CETUXIMAB | Y | N | 280024948 | CETUXIMAB |
| 280007559 | 280004851 | 1.73 | 102.8 | Neo-adjuvant (N) | 2014-10-28 | 2014-11-05 | CETUXIMAB | 02 | Y | 280024949 | CETUXIMAB |
| 280007560 | 280004852 | 1.7 | 72.8 | Palliative (P) | 2015-08-27 | 2015-08-29 | Docetaxel + Gemcitabine (prior RT) | null | null | 280024949 | DOCETAXEL + GEMCITABINE |
| 280007561 | 280004853 | 1.57 | null | Curative (C) | 2016-06-11 | 2016-07-10 | CETUXIMAB | N | N | 280024952 | CETUXIMAB |
| 280007562 | 280004857 | null | 93.4 | Adjuvant (A) | 2013-05-18 | 2013-06-14 | CISPLATIN + DOCETAXEL + FLUOROURACIL | 02 | N | 280024952 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280007563 | 280011882 | 1.82 | 57 | Neo-adjuvant (N) | 2017-07-26 | 2017-08-29 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | N | 280024954 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280007564 | 280004858 | null | 87.7 | Neo-adjuvant (N) | 2014-04-15 | 2014-05-27 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | null | 280024955 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280007565 | 280008574 | 0 | null | Neo-adjuvant (N) | 2014-01-25 | 2014-06-27 | EW EuroEwing 2012 Arm A VAC | 2 | N | 280024956 | NOT MATCHED |
| 280007566 | 280004862 | 1.7 | null | Curative (C) | 2016-02-29 | 2016-03-27 | Cetuximab 7 day (Cycle 1) | null | null | 280024957 | CETUXIMAB |
| 280007567 | 280008575 | 1.73 | 67.7 | Curative (C) | null | 2017-09-23 | CARBOPLATIN | N | N | 280024958 | CARBOPLATIN |
| 280007568 | 280004864 | 0 | 65 | Neo-adjuvant (N) | 2012-03-03 | 2014-04-09 | NB HRNBL-1 ch14.18/CHO only (trial) | N | N | 280024962 | NOT MATCHED |
| 280007569 | 280004864 | 1.8 | 93.6 | Palliative (P) | null | 2013-03-01 | Docetaxel+Gemcitabine (no prior RT) | 02 | N | 280024962 | DOCETAXEL + GEMCITABINE |
| 280007570 | 280004865 | 0 | 19.3 | Neo-adjuvant (N) | 2014-06-25 | 2014-06-28 | EW EuroEwing 2012 Arm B VC | N | Y | 280024968 | NOT MATCHED |
| 280007571 | 280008577 | 1.76 | 62.75 | Neo-adjuvant (N) | 2014-04-18 | 2014-04-27 | DOCETAXEL + GEMCITABINE | 02 | N | 280024968 | DOCETAXEL + GEMCITABINE |
| 280007572 | 280004867 | 1.65 | 78 | Curative (C) | 2013-11-13 | 2013-11-20 | CETUXIMAB | 02 | N | 280024982 | CETUXIMAB |
| 280007573 | 280004868 | 1.56 | 78.5 | Palliative (P) | 2015-11-29 | 2015-12-06 | Docetaxel + Gemcitabine (prior RT) | 02 | N | 280024984 | DOCETAXEL + GEMCITABINE |
| 280007574 | 280004869 | 1.73 | 99.4 | Curative (C) | 2017-03-21 | 2017-03-21 | Carboplatin AUC 2 - 5 | 02 | N | 280024986 | CARBOPLATIN |
| 280007575 | 280004870 | 1.79 | 75.75 | null | 2016-11-21 | 2017-04-30 | Cetuximab 7 day (>Cycle 2) | 02 | N | 280024990 | CETUXIMAB |
| 280007576 | 280004873 | 1.68 | 92.7 | Curative (C) | null | 2013-06-05 | Carboplatin AUC 6 - 10 | N | N | 280024990 | CARBOPLATIN |
| 280007577 | 280004873 | null | 85.9 | Neo-adjuvant (N) | 2013-09-26 | 2013-11-24 | CISPLATIN + DOCETAXEL + FLUOROURACIL | null | null | 280024990 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280007578 | 280004875 | 1.79 | 91 | Neo-adjuvant (N) | 2016-01-23 | 2016-07-01 | STS Rhabdomyosarcoma RMS 2005 IVAVV | Y | N | 280024997 | NOT MATCHED |
| 280007579 | 280004875 | 1.86 | 97.5 | Palliative (P) | 2016-07-15 | 2016-07-28 | DOCETAXEL + GEMCITABINE | 2 | null | 280024997 | DOCETAXEL + GEMCITABINE |
| 280007580 | 280004875 | 1.7 | 65.95 | Palliative (P) | 2017-08-11 | 2017-08-11 | DOCETAXEL + GEMCITABINE | 02 | N | 280024997 | DOCETAXEL + GEMCITABINE |
| 280007581 | 280011219 | null | 101 | Neo-adjuvant (N) | 2015-10-29 | 2015-12-14 | CISPLATIN + DOCETAXEL + FLUOROURACIL | 02 | N | 280025005 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280007582 | 280004877 | null | 73.8 | Neo-adjuvant (N) | 2015-11-03 | 2015-12-21 | CISPLATIN + DOCETAXEL + FLUOROURACIL | 02 | N | 280025015 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280007583 | 280004879 | 1.65 | 11.5 | Palliative (P) | 2016-08-03 | 2017-03-13 | DOCETAXEL + GEMCITABINE | 2 | null | 280025018 | DOCETAXEL + GEMCITABINE |
| 280007584 | 280010343 | 1.65 | 91.9 | Neo-adjuvant (N) | 2014-06-28 | 2014-07-01 | NB HRNBL-1 COJEC Ind COURSE B | N | N | 280025024 | NOT MATCHED |
| 280007585 | 280008585 | null | null | Curative (C) | 2015-10-20 | 2015-10-27 | Cisplatin + Docetaxel +Fluorouracil | N | N | 280025025 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280007586 | 280004883 | 1.82 | 90.9 | Palliative (P) | 2012-10-02 | 2013-06-08 | Docetaxel + Gemcitabine with GCSF | 02 | Y | 280025027 | DOCETAXEL + GEMCITABINE |
| 280007587 | 280004884 | 1.7 | 73.2 | Curative (C) | 2017-04-10 | 2017-04-10 | Carboplatin AUC 6 - 10 | N | N | 280025032 | CARBOPLATIN |
| 280007588 | 280008587 | 1.79 | null | Palliative (P) | 2013-07-09 | 2013-09-25 | Docetaxel + Gemcitabine (prior RT) | 02 | null | 280025033 | DOCETAXEL + GEMCITABINE |
| 280007589 | 280008587 | 1.8 | 108.5 | null | 2016-02-02 | 2016-02-28 | Cetuximab 7 day (>Cycle 2) | null | N | 280025033 | CETUXIMAB |
| 280007590 | 280004886 | null | 97 | Neo-adjuvant (N) | 2014-03-28 | 2014-05-09 | CISPLATIN + DOCETAXEL + FLUOROURACIL | 02 | N | 280025034 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280007591 | 280004889 | null | null | null | 2016-05-23 | 2016-05-30 | Cisplatin + Docetaxel +Fluorouracil | 01 | N | 280025036 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280007592 | 280004892 | 1.73 | 107 | Neo-adjuvant (N) | 2013-03-15 | 2014-10-13 | Docetaxel + Gemcitabine (prior RT) | N | null | 280025039 | DOCETAXEL + GEMCITABINE |
| 280007593 | 280004892 | 1.85 | 72.2 | Neo-adjuvant (N) | 2014-02-03 | 2014-03-28 | Cisplatin + Docetaxel +Fluorouracil | 02 | N | 280025039 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280007594 | 280011885 | null | 18 | Palliative (P) | 2017-04-24 | 2017-04-27 | STS Rhabdomyosarcoma RMS 2005 IVAVV | 02 | N | 280025041 | NOT MATCHED |
| 280007595 | 280004894 | null | null | Curative (C) | 2013-04-27 | 2013-04-27 | Cetuximab 7 day (>Cycle 2) | Y | N | 280025043 | CETUXIMAB |